# A Phase I Clinical Study on SHR6390 in Healthy Chinese Volunteers

> **NCT05354336** · PHASE1 · COMPLETED · sponsor: **The Affiliated Hospital of Qingdao University** · enrollment: 36 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** SHR6390(100mg)
- **DRUG:** SHR6390(125mg)
- **DRUG:** SHR6390(150mg)

## Key facts

- **NCT ID:** NCT05354336
- **Lead sponsor:** The Affiliated Hospital of Qingdao University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-13
- **Primary completion:** 2019-08-24
- **Final completion:** 2019-08-24
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2022-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05354336

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05354336, "A Phase I Clinical Study on SHR6390 in Healthy Chinese Volunteers". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05354336. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*